FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2071496654> ?p ?o ?g. }

• W2071496654 endingPage "715" @default.
• W2071496654 startingPage "706" @default.
• W2071496654 abstract "BACKGROUND: Epoetin α (EPO) continues to be the initial treatment of choice for most anemic patients with myelodysplastic syndromes (MDS). Over the years, different therapeutic strategies have been adopted to optimize the clinical benefits of EPO in this setting. METHODS: In the current meta-analysis of published literature, erythroid response (ER) rates with EPO as a single agent versus its combination with granulocyte–colony-stimulating factor (G-CSF) or granulocyte-macrophage–colony-stimulating factor (GM-CSF) were compared. RESULTS: The assessment indicated that the ER rates were comparable between the 2 EPO-based therapeutic strategies. Furthermore, EPO monotherapy at a higher dose of 60,000 to 80,000 U weekly produced significantly higher ER rates (64.5%) compared with the standard oncology dose of 30,000 to 40,000 U weekly either as a single agent (49%; P < .001) or in combination with G-CSF/GM-CSF (50.6% P = .007). In addition, when transfusion-dependent patients were assessed separately, both EPO monotherapy and its combination with G-CSF/GM-CSF produced comparable and appreciable levels of transfusion independence (28.8% and 24.8%, respectively). CONCLUSIONS: In the current meta-analysis, higher doses of EPO demonstrated better ER rates compared with EPO at standard doses alone or in combination with G-CSF/GM-CSF. Furthermore, the authors concluded that prospective clinical studies are warranted to evaluate the use of higher doses of EPO in anemic patients with MDS. Cancer 2009. © 2009 American Cancer Society." @default.
• W2071496654 created "2016-06-24" @default.
• W2071496654 creator A5015365593 @default.
• W2071496654 creator A5019269759 @default.
• W2071496654 creator A5028291559 @default.
• W2071496654 creator A5033630389 @default.
• W2071496654 creator A5043332548 @default.
• W2071496654 creator A5059232093 @default.
• W2071496654 date "2009-02-15" @default.
• W2071496654 modified "2023-10-11" @default.
• W2071496654 title "An assessment of erythroid response to epoetin α as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach" @default.
• W2071496654 cites W1531142686 @default.
• W2071496654 cites W186268426 @default.
• W2071496654 cites W187238933 @default.
• W2071496654 cites W1970566157 @default.
• W2071496654 cites W1970838494 @default.
• W2071496654 cites W1978522934 @default.
• W2071496654 cites W1979340496 @default.
• W2071496654 cites W1979820704 @default.
• W2071496654 cites W1995891393 @default.
• W2071496654 cites W1996887331 @default.
• W2071496654 cites W1999710442 @default.
• W2071496654 cites W2009867823 @default.
• W2071496654 cites W2014190277 @default.
• W2071496654 cites W2014903824 @default.
• W2071496654 cites W2021333892 @default.
• W2071496654 cites W2021571108 @default.
• W2071496654 cites W2028608050 @default.
• W2071496654 cites W2039777360 @default.
• W2071496654 cites W2050299158 @default.
• W2071496654 cites W2052480622 @default.
• W2071496654 cites W2058820265 @default.
• W2071496654 cites W2072122397 @default.
• W2071496654 cites W2080361105 @default.
• W2071496654 cites W2081279521 @default.
• W2071496654 cites W2109685720 @default.
• W2071496654 cites W2110949925 @default.
• W2071496654 cites W2114492363 @default.
• W2071496654 cites W2133016731 @default.
• W2071496654 cites W2136618123 @default.
• W2071496654 cites W2154703904 @default.
• W2071496654 cites W2159156084 @default.
• W2071496654 cites W2174401300 @default.
• W2071496654 cites W2412900863 @default.
• W2071496654 doi "https://doi.org/10.1002/cncr.24090" @default.
• W2071496654 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19152429" @default.
• W2071496654 hasPublicationYear "2009" @default.
• W2071496654 type Work @default.
• W2071496654 sameAs 2071496654 @default.
• W2071496654 citedByCount "55" @default.
• W2071496654 countsByYear W20714966542012 @default.
• W2071496654 countsByYear W20714966542013 @default.
• W2071496654 countsByYear W20714966542014 @default.
• W2071496654 countsByYear W20714966542015 @default.
• W2071496654 countsByYear W20714966542016 @default.
• W2071496654 countsByYear W20714966542017 @default.
• W2071496654 countsByYear W20714966542018 @default.
• W2071496654 countsByYear W20714966542019 @default.
• W2071496654 countsByYear W20714966542021 @default.
• W2071496654 countsByYear W20714966542022 @default.
• W2071496654 countsByYear W20714966542023 @default.
• W2071496654 crossrefType "journal-article" @default.
• W2071496654 hasAuthorship W2071496654A5015365593 @default.
• W2071496654 hasAuthorship W2071496654A5019269759 @default.
• W2071496654 hasAuthorship W2071496654A5028291559 @default.
• W2071496654 hasAuthorship W2071496654A5033630389 @default.
• W2071496654 hasAuthorship W2071496654A5043332548 @default.
• W2071496654 hasAuthorship W2071496654A5059232093 @default.
• W2071496654 hasBestOaLocation W20714966541 @default.
• W2071496654 hasConcept C126322002 @default.
• W2071496654 hasConcept C143998085 @default.
• W2071496654 hasConcept C203014093 @default.
• W2071496654 hasConcept C2776164570 @default.
• W2071496654 hasConcept C2776694085 @default.
• W2071496654 hasConcept C2777478134 @default.
• W2071496654 hasConcept C2777767877 @default.
• W2071496654 hasConcept C2777983669 @default.
• W2071496654 hasConcept C2778248108 @default.
• W2071496654 hasConcept C2778534260 @default.
• W2071496654 hasConcept C2778690821 @default.
• W2071496654 hasConcept C2780007613 @default.
• W2071496654 hasConcept C2780817109 @default.
• W2071496654 hasConcept C71924100 @default.
• W2071496654 hasConcept C90924648 @default.
• W2071496654 hasConceptScore W2071496654C126322002 @default.
• W2071496654 hasConceptScore W2071496654C143998085 @default.
• W2071496654 hasConceptScore W2071496654C203014093 @default.
• W2071496654 hasConceptScore W2071496654C2776164570 @default.
• W2071496654 hasConceptScore W2071496654C2776694085 @default.
• W2071496654 hasConceptScore W2071496654C2777478134 @default.
• W2071496654 hasConceptScore W2071496654C2777767877 @default.
• W2071496654 hasConceptScore W2071496654C2777983669 @default.
• W2071496654 hasConceptScore W2071496654C2778248108 @default.
• W2071496654 hasConceptScore W2071496654C2778534260 @default.
• W2071496654 hasConceptScore W2071496654C2778690821 @default.
• W2071496654 hasConceptScore W2071496654C2780007613 @default.
• W2071496654 hasConceptScore W2071496654C2780817109 @default.
• W2071496654 hasConceptScore W2071496654C71924100 @default.

• next